approv
therapi
ebola
viru
infect
find
potenti
therapeut
target
perform
screen
gene
essenti
ebola
viru
ebov
infect
identifi
gnptab
encod
subunit
transferas
show
ebov
infect
gnptab
knockout
cell
line
impair
revers
reconstitut
gnptab
express
fibroblast
patient
mucolipidosi
ii
disord
associ
mutat
gnptab
refractori
ebov
wherea
cell
healthi
parent
support
infect
impair
infect
correl
loss
express
cathepsin
b
known
essenti
ebov
entri
gnptab
activ
depend
upon
proteolyt
cleavag
proteas
inhibit
proteas
smallmolecul
block
ebov
entri
infect
disrupt
gnptab
function
may
repres
strategi
hosttarget
therapi
ebov
e
bolavirus
ebola
viru
ebov
reston
viru
restv
marburgvirus
marburg
viru
marv
singlestrand
negativesens
rna
genom
classifi
famili
filovirida
caus
sporad
outbreak
sever
hemorrhag
fever
case
fatal
rate
although
experiment
vaccin
therapeut
appear
promis
none
current
approv
protect
treat
filoviru
infect
ebov
particl
pleomorph
often
long
filament
structur
lipid
envelop
decor
viral
glycoprotein
gp
current
model
ebov
entri
particl
bind
cell
intern
macropinocytosi
deliv
late
endosomeslysosom
leli
cathepsin
cellular
cystein
proteas
remov
glycan
cap
mucinlik
domain
gp
cleav
form
gp
cl
receptorbind
site
expos
interact
intracellular
receptor
niemannpick
interact
thought
prime
gp
prior
fusion
viral
cellular
membran
result
viral
genom
deposit
insid
target
cell
cytoplasm
integr
leli
membran
protein
regul
releas
cholesterol
lysosom
loss
function
associ
niemannpick
type
c
diseas
npc
rare
autosom
recess
lysosom
storag
diseas
lsd
cell
accumul
cholesterol
glycosphingolipid
leli
essenti
filoviru
infect
patient
fibroblast
refractori
ebov
marv
infect
heterozyg
mice
surviv
normal
lethal
challeng
mouseadapt
ebov
marv
identifi
cellular
factor
requir
ebov
entri
smallmolecul
inhibitor
screen
lossoffunct
genetrap
method
haploid
cell
line
latter
studi
carett
colleagu
use
cell
transduc
genetrap
retroviru
infect
recombin
vesicular
stomat
viru
vsv
bear
ebov
glycoprotein
surviv
cell
expand
insert
site
map
strongest
hit
screen
hit
includ
gene
homotyp
fusion
vacuol
protein
sort
hop
complex
involv
fusion
endosom
lysosom
cathepsin
b
ctsb
lipid
kinas
pikfyv
transferas
alpha
beta
subunit
gnptab
anoth
genomewid
screen
use
shortinterf
rna
sirna
cell
use
lentiviru
bear
marv
glycoprotein
author
report
hop
complex
subunit
cathepsin
l
ctsl
hit
third
screen
use
short
hairpin
rna
shrna
method
cell
infecti
ebov
identifi
ctsb
hop
complex
subunit
addit
gene
import
endosom
matur
pikfyv
lysosom
protein
gtpase
involv
regul
vesicl
traffick
report
final
martin
colleagu
recent
screen
sirna
librari
ebov
minigenom
version
genom
viral
gene
replac
report
replic
coexpress
viral
protein
identifi
host
factor
import
replic
transcript
cell
screen
identifi
carbamoylphosph
synthetas
aspart
transcarbamylas
dihydroorotas
cad
de
novo
pyrimidin
synthesi
pathway
essenti
ebov
replic
transcript
lysosom
mediat
degrad
extraand
intracellular
materi
array
hydrolas
includ
proteas
cathepsin
cathepsin
b
catb
essenti
factor
ebov
entri
cell
cultur
cathepsin
l
catl
play
accessori
role
togeth
mediat
stepwis
cleavag
gp
gp
cl
mani
protein
transport
lysosom
via
pathway
transferas
glcnacphosphotransferas
golgiresid
enzym
particip
format
mannos
glycan
newli
synthes
protein
recogn
receptor
transport
lysosom
glcnacphosphotransferas
kilodalton
kda
heterotrim
structur
gnptab
gene
encod
wherea
encod
gnptg
activ
gnptab
polypeptid
must
cleav
subunit
cellular
proteas
low
level
glcnacphosphotransferas
activ
associ
lsd
mucolipidosi
slowli
progress
metabol
diseas
lysosom
hydrolas
improperli
target
rather
traffick
lysosom
becom
secret
mucolipidosi
type
ii
mlii
also
call
inclusioncel
icel
diseas
associ
variant
gnptab
result
littl
function
glcnacphosphotransferas
mucolipidosi
type
iii
alphabeta
mliii
alphabeta
also
call
pseudohurl
polydystrophi
associ
gnptab
variant
retain
residu
glcnacphosphotransferas
activ
mliii
alphabeta
progress
slowli
gener
less
sever
mlii
third
lsd
mucolipidosi
type
iii
gamma
mliii
gamma
caus
variant
gnptg
identifi
cellular
factor
requir
ebov
infect
might
target
hostdirect
therapi
perform
wholegenom
cluster
regularli
interspac
short
palindrom
repeat
crispr
screen
rather
use
recombin
vsv
encod
ebov
gp
use
authent
infecti
ebov
biosafeti
level
laboratori
screen
identifi
gnptab
host
factor
ebov
infect
requir
confirm
primari
cell
mlii
mliii
patient
defect
gnptab
variant
furthermor
find
inhibitor
proteas
requir
gnptab
activ
block
ebov
infect
suggest
target
gnptab
may
strategi
hosttarget
antivir
therapi
ebov
crispr
screen
gene
import
ebov
replic
genomewid
screen
use
genetrap
sirna
shrna
method
use
identifi
hostfactor
requir
filoviru
infect
perform
wholegenom
crispr
screen
use
librari
cell
use
authent
ebov
mayinga
strain
infect
librarytransduc
cell
multipl
infect
moi
fig
extens
cell
death
occur
infect
cultur
surviv
cell
expand
genom
dna
extract
singl
guid
rna
sgrna
sequenc
determin
sever
gene
significantli
enrich
sgrna
identifi
tabl
supplementari
data
toprank
hit
sgrna
enrich
second
hit
spinsterlik
encod
put
sugar
transport
involv
lysosom
function
third
hit
solut
carrier
famili
member
encod
zinc
transport
protein
work
requir
confirm
role
protein
ebov
infect
hit
includ
previous
report
subunit
hop
complex
tabl
uvrag
ultraviolet
radiat
resistanceassoci
requir
influenza
vsv
entri
previous
implic
ebov
infect
also
found
ctsl
minor
hit
ctsb
signific
altogeth
result
suggest
screen
capabl
identifi
gene
requir
ebov
infect
three
six
sgrna
enrich
gnptab
strong
hit
screen
also
carett
colleagu
decid
investig
role
ebov
infect
gnptab
requir
effici
ebov
infect
determin
gnptab
role
ebov
infect
crispr
genom
edit
use
gener
clonal
gnptabknockout
cell
line
control
cell
line
mutat
gene
interest
confirm
sequenc
sinc
select
screen
base
surviv
transduc
cell
follow
ebov
infect
first
test
viabil
cell
infect
parent
cell
gnptab
deriv
infect
viabil
determin
day
post
infect
due
ebovinduc
cytopath
effect
viabil
parent
cell
reduc
mockinfect
cell
wherea
gnptab
viabl
infect
fig
cell
infect
recombin
ebov
express
fluoresc
report
protein
zsgreen
ebovzsg
robust
fluoresc
observ
parent
cell
fluoresc
lower
gnptab
cell
lowest
cell
fig
effect
due
differ
cell
growth
mockinfect
cultur
similar
growth
rate
supplementari
figur
test
abil
cell
support
infect
wildtyp
ebov
less
viru
yield
gnptab
cell
parent
cell
confirm
role
gnptab
ebov
infect
lentivirus
express
gnptab
ctermin
myctag
gnptabmyc
gu
control
use
transduc
parent
gnptab
cell
detect
endogen
gnptab
three
differ
commerci
avail
antibodi
test
could
detect
gnptabmyc
appropri
transduc
cell
popul
fig
b
transduc
cell
line
still
express
fig
infect
ebov
gnptab
cell
transduc
express
gu
gnptab
gu
remain
refractori
ebovinduc
cell
death
wherea
viabil
reconstitut
gnptabmyc
significantli
reduc
fig
addit
gnptabmyc
reconstitut
cell
support
infect
ebovzsg
wherea
infect
remain
impair
cell
transduc
express
gu
fig
abil
support
ebov
infect
correl
growth
rate
grew
similarli
supplementari
figur
addit
growth
lasvzsg
similar
reconstitut
cell
line
supplementari
figur
altogeth
data
indic
gnptab
requir
effici
ebov
infect
haploid
cell
line
variant
gnptab
associ
lsd
mucolipidosi
obtain
primari
fibroblast
famili
three
patient
mlii
famili
cell
healthi
mother
father
well
proband
mlii
patient
test
characterist
cell
describ
detail
previous
summar
tabl
fibroblast
three
appar
healthi
patient
three
patient
npc
serv
neg
posit
control
respect
healthi
control
fibroblast
support
infect
ebovzsg
fig
supplementari
figur
contrast
fibroblast
npc
patient
fail
support
detect
ebov
replic
fig
c
third
npc
cell
line
support
delay
low
level
infect
fig
patient
compound
heterozyg
allel
variant
well
character
associ
npc
variant
found
nonpathogen
consist
reduc
level
infect
observ
fibroblast
famili
mlii
patient
infect
case
matern
patern
cell
support
ebovzsg
infect
proband
cell
fig
level
infect
cell
three
mlii
proband
compar
cell
npc
patient
growth
rate
fibroblast
cell
correl
abil
support
ebov
infect
supplementari
figur
fibroblast
two
mlii
proband
three
healthi
control
patient
infect
lasvzsg
ahfv
rvfvgfp
growth
ahfv
rvfvgfp
mlii
proband
cell
unimpair
similar
healthi
fibroblast
supplementari
figur
e
lasvzsg
viru
yield
similar
mlii
healthi
fibroblast
timecours
modestli
lower
mlii
cell
day
timepoint
supplementari
figur
overal
suggest
impair
growth
ebov
cell
simpli
due
gener
lack
support
viral
infect
understand
relationship
gnptab
dysfunct
ebov
infect
test
fibroblast
six
tabl
comparison
screen
previous
report
screen
carett
cheng
filon
martin
posit
check
screen
indic
pvalu
calcul
mageck
cheng
filon
screen
report
full
result
gene
discuss
author
shown
simian
viru
expect
minigenom
recapitul
viral
entri
mechan
patient
mliii
less
sever
form
mucolipidosi
usual
character
residu
level
glcnacphosphotransferas
activ
cell
mliii
alphabeta
patient
variant
gnptab
mliii
gamma
patient
variant
gnptg
test
tabl
kda
detect
gnptabcel
express
restor
follow
reconstitut
gnptabmyc
fig
supplementari
figur
b
sinc
catb
essenti
zaireebov
entri
perform
assay
catb
function
use
fluoresc
substrat
peptid
becom
dequench
proteolysi
use
inhibitor
catb
b
catl
l
demonstr
catb
activ
specif
detect
lysat
parent
cell
knockout
cell
possess
robust
catb
activ
fig
inhibit
ad
b
l
contrast
catb
activ
significantli
lower
gnptab
knockout
cell
fig
catb
activ
restor
gnptabmyc
express
fig
data
consist
gnptab
influenc
ebov
infect
modul
activ
catb
critic
factor
ebov
entri
inhibitor
gnptab
process
block
ebov
infect
proteas
requir
cleavag
gnptab
enabl
glcnacphosphotransferas
activ
hypothes
inhibitor
would
inhibit
ebov
infect
block
gnptab
activ
first
determin
could
prevent
cleavag
gnptab
precursor
alpha
beta
subunit
cell
transfect
express
gnptabmyc
treat
increas
concentr
exhibit
less
process
evidenc
reduc
amount
fig
effect
express
level
fig
examin
effect
ebovgpmedi
entri
use
pseudotyp
lentivir
particl
bear
ebovgp
ebovpp
compound
block
ebovpp
entri
mean
effect
concentr
ec
sd
n
fig
wherea
inhibit
particl
pseudotyp
vsvg
protein
vsvpp
ec
n
fig
similar
effect
cell
viabil
fig
inhibit
ebovzsg
viru
infect
mean
ec
n
select
index
si
fig
control
compound
block
ahfvinduc
cpe
cell
effect
supplementari
figur
similarli
rvfvgfp
fluoresc
cell
inhibit
control
inhibit
fig
supplementari
figur
thu
inhibitor
block
gnptab
matur
specif
inhibit
ebovgpmedi
entri
ebov
infect
sever
genomewid
screen
identifi
hostfactor
requir
filoviru
infect
report
may
gnptab
hit
two
screen
use
gene
knockout
use
rnai
tabl
use
authent
ebov
challeng
viru
benefit
recapitul
genuin
infect
process
ebov
propens
form
defectiveinterf
particl
may
caus
falseposit
hit
note
addit
gene
requir
ebov
infect
gene
requir
death
ebovinfect
cell
also
identifi
screen
gnptab
gene
encod
subunit
glcnacphosphotransferas
enzym
particip
format
protein
direct
transport
lysosom
confirm
role
gnptab
ebov
infect
cell
primari
fibroblast
individu
mucolipidosi
genet
disord
associ
mutat
gnptab
gnptab
requir
correct
local
numer
lysosom
hydrolas
exclud
involv
factor
lack
ebov
infect
correl
loss
catb
activ
known
requir
ebov
entri
model
role
gnptab
ebov
entri
shown
fig
lysosom
cystein
proteas
requir
activ
gp
filovirus
differ
virus
use
differ
cathepsin
exampl
entri
mediat
ebov
gp
strongli
depend
upon
catb
wherea
marv
gp
depend
upon
catl
restv
gp
sensit
loss
catb
catl
inhibit
broad
cystein
proteas
inhibitor
suggest
differ
cystein
proteas
requir
restv
infect
found
restv
infect
gnptabcel
impair
supplementari
figur
consist
restv
gp
activ
depend
upon
lysosom
proteas
transport
action
gnptab
addit
cystein
proteas
requir
even
virus
use
catb
virus
bear
precleav
glycoprotein
remain
sensit
inhibit
consist
multistep
model
initi
cleavag
catb
l
expos
domain
addit
step
mediat
cathepsin
reduc
gnptabknockout
cell
restor
upon
gnptab
reconstitut
immunoblot
lysat
parent
knockout
reconstitut
cell
catb
catl
migrat
kda
molecular
mass
marker
shown
right
b
catb
activ
lysat
parent
knockout
gnptabor
cell
treat
cathepsin
b
inhibitor
bi
cathepsin
l
inhibitor
li
dmso
vehicl
control
h
lysi
incub
fluoresc
catb
peptid
substrat
h
incub
room
temperatur
fluoresc
measur
data
repres
mean
sd
three
technic
replic
repres
three
independ
experi
shown
c
catb
activ
lysat
reconstitut
cell
lysat
transduc
gnptab
cell
gener
test
catb
activ
panel
b
data
repres
mean
sd
three
technic
replic
repres
two
independ
experi
shown
panel
b
c
statist
analysi
perform
twotail
student
ttest
signific
shown
p
anoth
lysosom
proteas
requir
fusion
occur
interestingli
wildtyp
ctsb
ctsl
mice
equal
suscept
lethal
challeng
mouseadapt
ebov
suggest
vivo
least
mouseadapt
ebov
mice
gp
may
cleav
proteas
catb
catl
could
due
differ
specif
differ
speci
cathepsin
may
also
case
human
infect
one
effect
modul
gnptab
function
may
inactiv
multipl
cathepsin
unlik
small
molecul
direct
singl
cathepsin
might
effect
block
multipl
filovirus
show
gnptabknockout
reduc
marv
infect
though
extent
seen
ebov
supplementari
figur
also
restvinfect
supplementari
figur
inhibit
gnptab
would
also
predict
block
infect
virus
requir
cathepsin
nipah
viru
supplementari
figur
sarscoronaviru
reovirus
cathepsin
thought
involv
antigen
process
gener
peptid
present
major
histocompat
complex
class
ii
molecul
surfac
antigenpres
cell
consequ
suppress
gnptab
function
may
prevent
initi
adapt
immun
respons
though
unabl
find
refer
immun
suppress
context
mucolipidosi
patient
clearli
antivir
strategi
target
gnptab
therapi
consequ
patient
physiolog
need
fulli
evalu
found
inhibitor
proteas
requir
gnptab
matur
inhibit
ebovgpmedi
entri
ebov
infect
origin
develop
reduc
cholesterol
fatti
acid
synthesi
also
respons
process
sterol
regulatori
elementbind
protein
major
transcript
regul
cholesterol
synthesi
inhibit
activ
ic
cholesterol
synthesi
ec
recent
demonstr
cholesterollow
drug
statin
suppress
ebov
infect
interf
proper
gp
process
similarli
cholesterolreduc
function
may
also
prevent
correct
gp
glycosyl
mechan
may
contribut
antiebov
activ
inde
inhibit
infect
number
virus
cell
cultur
requir
matur
glycoprotein
depend
upon
high
level
cellular
cholesterol
entri
inactiv
gnptab
improp
traffick
lysosom
protein
addit
mechan
may
contribut
antivir
activ
compound
notabl
howev
high
clearanc
rate
mlminkg
low
oral
avail
fail
protect
mice
sever
fever
upon
challeng
thrombocytopenia
syndrom
viru
data
suggest
gnptab
could
subject
hosttarget
antiebov
therapi
use
compound
like
block
gnptab
function
consequ
lysosom
cathepsin
activ
inhibit
ebov
infect
treatment
would
essenti
involv
deliber
induct
lsd
prevent
ebov
enter
via
lysosom
suggest
previous
suppress
gnptab
defici
associ
mucolipidosi
clinic
manifest
occur
much
slowli
acut
cours
ebov
infect
risk
shortterm
gnptab
inhibit
may
outweigh
benefit
diseas
high
case
fatal
rate
found
fibroblast
sever
patient
mliii
less
sever
form
mucolipidosi
associ
residu
level
glcnacphosphotransferas
activ
effici
support
ebov
growth
suggest
even
partial
reduct
gnptab
activ
might
suffici
reduc
infect
conclus
demonstr
gnptab
requir
effici
ebov
infect
suggest
host
pathway
may
target
part
antiebov
therapeut
strategi
biosafeti
work
infecti
viru
conduct
laboratori
center
diseas
control
prevent
cdc
atlanta
usa
laboratorian
adher
intern
practic
appropri
biosafeti
level
experi
involv
cdna
encod
viral
sequenc
approv
cdc
institut
biosafeti
committe
vero
cell
cdc
core
facil
maintain
dmem
supplement
vv
fc
cell
cultur
co
test
period
rule
mycoplasma
contamin
wildtyp
ebov
strain
mayinga
launch
recombin
dna
cotransfect
cell
plasmid
encod
fulllength
genom
codonoptim
ebov
protein
np
l
rna
polymeras
four
day
post
transfect
clarifi
medium
transfect
cell
pass
onto
fresh
monolay
medium
cell
harvest
day
later
titer
cell
stock
gener
follow
infect
cell
moi
avoid
emerg
defectiveinterf
particl
recombin
virus
ebovzsg
lasvzsg
marvzsg
nivzsg
rvfvgfp
engin
gene
encod
fluoresc
pool
crispr
screen
pool
crispr
screen
perform
twice
librari
coverag
time
gecko
librari
gift
feng
zhang
acquir
addgen
watertown
usa
vsvgpseudotyp
lentivirus
gener
univers
michigan
vector
core
packag
b
lentivir
halflibrari
use
transduc
million
cell
moi
dish
transduct
cell
select
day
puromycin
frozen
transfer
cdc
follow
reviv
halflibrari
transduc
cell
infect
wildtyp
ebov
mayinga
strain
moi
three
day
post
infect
cell
passag
ratio
surviv
cell
expand
lyse
tripur
roch
appli
scienc
mannheim
germani
inactiv
ebov
present
sampl
lysat
transfer
contain
laboratori
genom
dna
gdna
extract
use
tripur
method
sgrna
sequenc
amplifi
two
sequenti
pcr
reaction
use
herculas
ii
enzym
agil
santa
clara
usa
first
reaction
gdna
ebovselect
cell
input
librari
cell
replic
reaction
set
extract
gdna
product
amplifi
cycl
use
primer
pcr
revers
list
supplementari
viru
assay
assay
measur
ebovinduc
cpe
cell
seed
cell
per
well
plate
next
day
cell
infect
wildtyp
ebov
strain
mayinga
moi
three
day
postinfect
pi
cell
trypsin
pass
ratio
opaqu
white
plate
six
day
pi
cell
viabil
determin
use
celltiterglo
accord
manufactur
instruct
promega
madison
usa
timecours
use
fluoresc
report
virus
ebovzsg
lasvzsg
rvfvgfp
cell
seed
cell
fibroblast
cell
per
well
opaqu
plate
follow
day
cell
infect
ebovzsg
viru
moi
fibroblast
infect
moi
titer
determin
use
healthi
control
fibroblast
fluoresc
repres
intens
within
infect
cell
measur
time
use
synergi
plate
reader
biotek
winooski
usa
timecours
measur
viral
titer
cell
seed
infect
fluoresc
virus
sampl
cultur
medium
quantifi
viru
titer
tissu
cultur
infecti
dose
tcid
assay
vero
cell
method
reed
muench
assay
test
inhibit
ebovgpmedi
entri
perform
pseudotyp
hiv
particl
particl
gener
cotransfect
lentix
cell
lipofectamin
thermofish
plasmid
express
ebovgp
vsvg
hiv
luciferas
report
vector
contain
defect
nef
env
vpr
obtain
nih
aid
reagent
program
divis
aid
niaid
nih
e
dr
nathaniel
landau
ratio
transfect
cell
supernat
harvest
h
post
transfect
pool
pass
polyethylsulfon
filter
remov
debri
aliquot
frozen
lentix
rapid
titer
kit
takara
bio
use
determin
hiv
core
protein
content
stock
measur
pseudotyp
entri
cell
seed
cell
per
well
plate
follow
day
cell
treat
vari
concentr
h
pseudotyp
particl
ad
ng
hiv
matrix
protein
per
well
six
hour
later
inoculum
remov
replac
complet
medium
firefli
luciferas
activ
determin
use
brightglo
luciferas
assay
system
promega
day
later
assay
inhibit
ebovzsg
infect
perform
cell
cell
seed
per
well
plate
follow
day
cell
treat
vari
concentr
h
infect
ebovzsg
viru
moi
zsgreen
fluoresc
measur
day
later
use
synergi
plate
reader
assay
catb
activ
assay
measur
catb
activ
cell
detach
plate
use
enzymefre
celldissoci
buffer
thermofish
cell
transfer
ml
microfug
tube
ml
medium
supplement
catb
inhibitor
b
zphealach
f
calbiochem
milliporesigma
burlington
usa
catl
inhibitor
l
zphetyr
tbu
diazomethylketon
calbiochem
dmso
vehicl
cell
incub
h
wash
twice
pb
resuspend
lysi
buffer
mm
sodium
acet
ph
mm
edta
vv
triton
insolubl
materi
pellet
microfug
min
supernat
harvest
well
black
opaqu
plate
cell
lysat
ad
reaction
buffer
mm
sodium
acet
ph
mm
edta
mm
dithiothreitol
substrat
solut
catb
substrat
peptid
zargargamc
calbiochem
resuspend
lysi
buffer
reaction
incub
room
temperatur
h
fluoresc
measur
excit
nm
emiss
nm
use
synergi
plate
reader
graph
statist
concentrationrespons
plot
graphpad
prism
graphpad
softwar
la
jolla
usa
use
fit
equat
semilog
plot
data
deriv
concentr
compound
inhibit
measur
effect
ec
statist
analys
also
perform
graphpad
prism
student
ttest
p
valu
consid
statist
signific
bar
graph
individu
data
point
overlaid
disclaim
find
conclus
report
author
necessarili
repres
offici
posit
center
diseas
control
prevent
